Active Shortage

JAMP PENTOXIFYLLINE SR

JAMP PHARMA CORPORATION

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of JAMP PENTOXIFYLLINE SR in Canada?

Yes. JAMP PENTOXIFYLLINE SR 400MG has an active shortage reported to Health Canada (last updated August 26, 2026).

Why is JAMP PENTOXIFYLLINE SR not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will JAMP PENTOXIFYLLINE SR be available again?

The manufacturer's estimated resolution date is December 11, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusActive Shortage

Same-ingredient products on fileNone found

Expected resolution~29 days remaining (estimate)

Affected strength400MG

Report last updated2026-08-26

Checked by MedShort2026-11-12

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

JAMP Pentoxifylline SR

JAMP Pentoxifylline SR 400mg: Affected lot may contain Sitagliptin 100mg tablets.

Type III2025-05-05

Low health risk

Possible match — not confirmed

DIN

02543087

Strength

400MG

Dosage Form

TABLET (EXTENDED-RELEASE)

Route

ORAL

Active Ingredient

PENTOXIFYLLINE

See all PENTOXIFYLLINE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-08-26

Active Shortage

Disruption of the manufacture of the drug.

Other Products from JAMP PHARMA CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACTIVATED CHARCOAL

225MG · DIN 02420694

AMIKACIN SULFATE INJECTION

250MG · DIN 02529459

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02423227

AMLODIPINE

5MG · DIN 02429217

AMLODIPINE

2.5MG · DIN 02492199

AMLODIPINE

10MG · DIN 02429225